To address these questions, in this report we aim to investigate BCR signaling, particularly focusing on SYK, BTK, and PLCγ2 activity, in peripheral blood B cells from untreated and nintedanib-treated IPF patients, as well as the connection with circulating BAFF. The gene discussed is BTK; the disease is idiopathic pulmonary fibrosis.